Janus Henderson Group plc 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 1:03 pm Sale | 2023-06-06 | 13G | Bellerophon Therapeutics, Inc. BLPH | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -1,263,065 (Position Closed) | Filing |
| 2023-05-26 4:41 pm Purchase | 2023-05-23 | 13G | Bellerophon Therapeutics, Inc. BLPH | JANUS HENDERSON GROUP PLC JHG | 1,263,065 12.100% | 726,631 (+135.46%) | Filing |
| 2023-05-25 11:17 am Purchase | 2023-05-15 | 13G | Bellerophon Therapeutics, Inc. BLPH | JANUS HENDERSON GROUP PLC JHG | 536,434 5.100% | 536,434 (New Position) | Filing |